Immune Thrombocytopenia Clinical Trials in Wuhan, Hubei
3 recruitingWuhan, Hubei, China
Showing 1–3 of 3 trials
Recruiting
Early Phase 1
Safety and Efficacy of PRG-1801 in Recurrent/Refractory Primary Immune Thrombocytopenia (ITP)
Immune Thrombocytopenia
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology6 enrolled2 locationsNCT06519565
Recruiting
Phase 1
Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
Immune Thrombocytopenia
Guangdong Hengrui Pharmaceutical Co., Ltd10 enrolled1 locationNCT07206758
Recruiting
Phase 3
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia
Chronic Primary Immune Thrombocytopenia (ITP)
Beijing InnoCare Pharma Tech Co., Ltd.195 enrolled45 locationsNCT06004856